Literature DB >> 21221794

miR-137 is frequently down-regulated in gastric cancer and is a negative regulator of Cdc42.

Qingjiang Chen1, Xiaobing Chen, Mingzhi Zhang, Qingxia Fan, Suxia Luo, Xinguang Cao.   

Abstract

INTRODUCTION: MicroRNAs (miRNAs) are a class of small (19-25 nucleotides) noncoding RNAs that regulate the expressions of a wide variety of genes, including some involved in cancer development. Some recent studies show that DNA methylation contributes to down-regulation of microRNA-137 (miR-137) during tumorigenesis. Whether down-regulation of miR-137 also exists in gastric cancer is unknown. AIM: Our aim was to test the hypothesis that down-regulation of miR-137 also exists in gastric cancer.
METHODS: Expression of levels of miR-137 were examined using real-time PCR on paired gastric cancer and adjacent non-cancerous tissues. The methylation status is detected by MSP.
RESULTS: Results show that miR-137 is downregulated by hypermethylation of the promoter in gastric cancer tissues. Epigenetic silencing of miR-137 induced an up-regulation of its targets, Cdc42. Restoration of the miR-137 expression in gastric cancer cell lines downregulated the Cdc42 expression. Restoration of the miR-137 and inactivation of Cdc42 induce apoptosis and cell cycle G1 arrest in gastric cancer cells. Furthermore, the miR-137 expression was found to be inversely correlated with CDC42 expression in gastric caner.
CONCLUSIONS: miR-137 is frequently down-regulated in gastric cancer and is a negative regulator of Cdc42.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21221794     DOI: 10.1007/s10620-010-1536-3

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  17 in total

Review 1.  How microRNAs control cell division, differentiation and death.

Authors:  Eric A Miska
Journal:  Curr Opin Genet Dev       Date:  2005-10       Impact factor: 5.578

2.  Gene targeting of Cdc42 and Cdc42GAP affirms the critical involvement of Cdc42 in filopodia induction, directed migration, and proliferation in primary mouse embryonic fibroblasts.

Authors:  Linda Yang; Lei Wang; Yi Zheng
Journal:  Mol Biol Cell       Date:  2006-08-16       Impact factor: 4.138

3.  miR-137 targets Cdc42 expression, induces cell cycle G1 arrest and inhibits invasion in colorectal cancer cells.

Authors:  Ming Liu; Nan Lang; Meng Qiu; Feng Xu; Qiu Li; Qiulin Tang; Ji Chen; Xi Chen; Siyuan Zhang; Zhen Liu; Jitao Zhou; Yajie Zhu; Yu Deng; Yi Zheng; Feng Bi
Journal:  Int J Cancer       Date:  2011-03-15       Impact factor: 7.396

4.  The small Rho GTPase Cdc42 regulates neutrophil polarity via CD11b integrin signaling.

Authors:  Kathleen Szczur; Yi Zheng; Marie-Dominique Filippi
Journal:  Blood       Date:  2009-09-14       Impact factor: 22.113

5.  Epigenetic silencing of miR-137 is an early event in colorectal carcinogenesis.

Authors:  Francesc Balaguer; Alexander Link; Juan Jose Lozano; Miriam Cuatrecasas; Takeshi Nagasaka; C Richard Boland; Ajay Goel
Journal:  Cancer Res       Date:  2010-08-03       Impact factor: 12.701

6.  Epigenetic repression of microRNA-129-2 leads to overexpression of SOX4 oncogene in endometrial cancer.

Authors:  Yi-Wen Huang; Joseph C Liu; Daniel E Deatherage; Jingqin Luo; David G Mutch; Paul J Goodfellow; David S Miller; Tim H-M Huang
Journal:  Cancer Res       Date:  2009-11-03       Impact factor: 12.701

7.  The Cdc42-interacting protein-4 (CIP4) gene knock-out mouse reveals delayed and decreased endocytosis.

Authors:  Yanming Feng; Sean M Hartig; John E Bechill; Elisabeth G Blanchard; Eva Caudell; Seth J Corey
Journal:  J Biol Chem       Date:  2009-11-17       Impact factor: 5.157

8.  Overexpression of RhoA, Rac1, and Cdc42 GTPases is associated with progression in testicular cancer.

Authors:  Takao Kamai; Tomonori Yamanishi; Hiromichi Shirataki; Kentaro Takagi; Hidekazu Asami; Yuji Ito; Ken-Ichiro Yoshida
Journal:  Clin Cancer Res       Date:  2004-07-15       Impact factor: 12.531

9.  Cdc42 is highly expressed in colorectal adenocarcinoma and downregulates ID4 through an epigenetic mechanism.

Authors:  Teresa Gómez Del Pulgar; Fátima Valdés-Mora; Eva Bandrés; Rosa Pérez-Palacios; Carolina Espina; Paloma Cejas; Miguel Angel García-Cabezas; Manuel Nistal; Enrique Casado; Manuel González-Barón; Jesús García-Foncillas; Juan Carlos Lacal
Journal:  Int J Oncol       Date:  2008-07       Impact factor: 5.650

10.  Genomic profiling of microRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitro.

Authors:  Lars Dyrskjøt; Marie S Ostenfeld; Jesper B Bramsen; Asli N Silahtaroglu; Philippe Lamy; Ramshanker Ramanathan; Niels Fristrup; Jens L Jensen; Claus L Andersen; Karsten Zieger; Sakari Kauppinen; Benedicte P Ulhøi; Jørgen Kjems; Michael Borre; Torben F Orntoft
Journal:  Cancer Res       Date:  2009-06-01       Impact factor: 12.701

View more
  64 in total

1.  MiR-137 regulates epithelial-mesenchymal transition in gastrointestinal stromal tumor.

Authors:  Sheng Liu; Juan Cui; Guoqing Liao; Yi Zhang; Ke Ye; Tailiang Lu; Jing Qi; Guohui Wan
Journal:  Tumour Biol       Date:  2014-06-12

2.  MicroRNA-506 inhibits gastric cancer proliferation and invasion by directly targeting Yap1.

Authors:  Jun Deng; Wan Lei; Xiaojun Xiang; Ling Zhang; Feng Yu; Jun Chen; Miao Feng; Jianping Xiong
Journal:  Tumour Biol       Date:  2015-04-07

Review 3.  The role of microRNAs in cancers of the upper gastrointestinal tract.

Authors:  Shumei Song; Jaffer A Ajani
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-11-20       Impact factor: 46.802

Review 4.  MicroRNAs in tumorigenesis, metastasis, diagnosis and prognosis of gastric cancer.

Authors:  C Jiang; X Chen; M Alattar; J Wei; H Liu
Journal:  Cancer Gene Ther       Date:  2015-05-22       Impact factor: 5.987

5.  Diagnostic and prognostic significance of serum miR-24-3p in HBV-related hepatocellular carcinoma.

Authors:  Fan-Long Meng; Wei Wang; Wei-Dong Jia
Journal:  Med Oncol       Date:  2014-08-17       Impact factor: 3.064

Review 6.  MicroRNA and signaling pathways in gastric cancer.

Authors:  Z Zhang; Z Li; Y Li; A Zang
Journal:  Cancer Gene Ther       Date:  2014-07-25       Impact factor: 5.987

7.  Overexpressed miRNA-137 inhibits human glioma cells growth by targeting Rac1.

Authors:  Guan Sun; Ying Cao; Lei Shi; Lihua Sun; Yingyi Wang; Chen Chen; Zhengqiang Wan; Linshan Fu; Yongping You
Journal:  Cancer Biother Radiopharm       Date:  2013-05       Impact factor: 3.099

Review 8.  Epigenetic Mechanisms and Events in Gastric Cancer-Emerging Novel Biomarkers.

Authors:  Hasan Raza Kazmi; Soni Kumari; Satendra Tiwari; A Khanna; Gopeshwar Narayan
Journal:  Pathol Oncol Res       Date:  2018-03-19       Impact factor: 3.201

Review 9.  Rho GTPases: Regulation and roles in cancer cell biology.

Authors:  Raquel B Haga; Anne J Ridley
Journal:  Small GTPases       Date:  2016-09-14

Review 10.  DNA methylation and microRNA dysregulation in cancer.

Authors:  Hiromu Suzuki; Reo Maruyama; Eiichiro Yamamoto; Masahiro Kai
Journal:  Mol Oncol       Date:  2012-08-10       Impact factor: 6.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.